Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Sanofi to buy Nepentes for €105mm

Executive Summary

Sanofi-Aventis has launched a tender offer for publicly traded Polish consumer health care company Nepentes SA. The deal is valued at about €105mm ($128.8mm)--majority Nepentes stockholders will receive €6.37, while the smaller stakeholders get €6.86 per share.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
    • OTC, Consumer
Deal Status
  • Final
Deal Type
  • Acquisition
    • Full Acquisition
    • Payment Includes Cash

Related Companies

Advertisement
UsernamePublicRestriction

Register